| Literature DB >> 15500697 |
Mousa A Abujbara1, Hanan A Hamamy, Nadim S Jarrah, Nadima S Shegem, Kamel M Ajlouni.
Abstract
BACKGROUND: Proper management of patients with Kallmann syndrome (KS) allows them to attain a normal reproductive health. The purpose of this study is to demonstrate the presentation modalities, phenotypes and the modes of inheritance among 32 patients with Kallmann syndrome in Jordan. Recognition of the syndrome allows for prompt proper management and provision of genetic counselling.Entities:
Year: 2004 PMID: 15500697 PMCID: PMC533860 DOI: 10.1186/1742-4755-1-5
Source DB: PubMed Journal: Reprod Health ISSN: 1742-4755 Impact factor: 3.223
Figure 1Pedigrees of 12 families with KS
Clinical features of 26 males with Kallmann syndrome
| FAMILY | No | Age | Anosmia/hyposmia | Synkinesia | Hearing Impairment | Renal abnormalities | Azoospermia | cryptorchidism | Micropenis |
| 1 | 46 | +/H | - | + | - | + | + | - | |
| 2 | 14 | + | + | + | + | + | + | - | |
| 3 | 27 | + | + | - | + | + | + | - | |
| 4 | 20 | + | + | - | + | + | + | - | |
| 5 | 20 | + | + | - | + | + | + | - | |
| 6 | 19 | + | + | - | + | + | + | - | |
| 7 | 16 | + | + | - | + | + | + | - | |
| 8 | 14 | + | + | - | + | NA | + | - | |
| 9 | 9 | + | + | - | + | NA | + | + | |
| 10 | 6 | + | + | - | - | NA | - | + | |
| 11 | 4 | + | + | - | - | NA | + | + | |
| 1 | 37 | + | - | - | - | + | + | + | |
| 2 | 24 | + | - | ND* | ND* | ND* | + | + | |
| 3 | 22 | + | - | ND* | ND* | ND* | - | + | |
| 4 | 20 | + | - | ND* | ND* | ND* | + | + | |
| 1 | 14 | + | + | - | - | NA | - | + | |
| 2 | 10 | + | + | - | + | NA | - | + | |
| 3 | 8 | + | + | - | + | NA | - | + | |
| 1 | 6 | + | + | - | - | NA | + | + | |
| 2 | 5 | + | + | - | - | NA | + | + | |
| 1 | 20 | +/H | - | + | - | + | - | + | |
| 2 | 19 | +/H | + | + | + | + | - | + | |
| 1 | 19 | + | - | - | + | ND | + | - | |
| 1 | 37 | + | - | - | - | + | + | + | |
| 1 | 22 | + | - | - | + | + | + | + | |
| 1 | 20 | + | - | - | - | oligospermia | + | + |
NA: not applicable.
ND: not done.
*: lost contact
H: hyposmia
Clinical Features of 6 females with Kallmann syndrome
| FAMILY | No | Age | Anosmia/hyposmia | Synkinesia | Hearing loss | Renal abnormalities | Primary Amenorrhea |
| 1 | 23 | + | - | - | - | + | |
| 2 | 21 | + | - | - | - | + | |
| 3 | 18 | + | - | - | - | + | |
| 1 | 18 | +/H | - | - | - | + | |
| 1 | 30 | + | - | - | - | + | |
| 1 | 18 | +/H | - | - | - | + |
H: hyposmia
Hormonal profile and GnRH stimulation test in adult male patients with KS.
| FAMILY | Age | Inheritance | Base line LH (mIU/ml) | Peak LH (mIU/ml) after GnRH testing | Peak LH (mIU/ml) after priming | Baseline FSH (mIU/ml) | Peak FSH (mIU/ml) after GnRH testing | Peak FSH (mIU/ml) after priming | Testosterone ng/dl | |
| 1 | 46 | XR | 0.5 | 2.26 | 1.09 | 2.22 | 60 | |||
| 2 | 14 | XR | Undetected | 0.35 | 2.50 | 0.64 | 2.39 | 4.25 | Undetected | |
| 3 | 27 | XR | Undetected | 0.90 | 2.85 | 0.59 | 1.58 | 5.24 | Undetected | |
| 4 | 20 | XR | 0.6 | 2.90 | 1.66 | 3.43 | 80 | |||
| 5 | 20 | XR | 0.8 | 3.10 | 2.1 | 5.6 | 50 | |||
| 6 | 19 | XR | Undetected | 0.40 | 2.88 | 0.8 | 2.3 | 6.4 | Undetected | |
| 7 | 16 | XR | 0.6 | 3..50 | 1.35 | 3.21 | 50 | |||
| 1 | 37 | XR | Undetected | 0.50 | 3.25 | 0.43 | 2.14 | 6.34 | Undetected | |
| 2 | 24 | XR | ND | ND | ND | ND | ND | ND | ND | |
| 3 | 22 | XR | ND | ND | ND | ND | ND | ND | ND | |
| 4 | 20 | XR | ND | ND | ND | ND | ND | ND | ND | |
| 1 | 20 | XR | Undetected | 0.45 | 2.1 | 0.47 | 1.65 | 3.2 | Undetected | |
| 2 | 19 | XR | 0.42 | 4.36 | 0.90 | 5.22 | 40 | |||
| 1 | 19 | sporadic | 0.5 | 6.2 | 0.9 | 10.1 | 70 | |||
| 1 | 37 | sporadic | Undetected | 1.9 | 0.46 | 3.2 | Undetected | |||
| 1 | 22 | sporadic | 0.53 | 3.25 | 0.85 | 4.50 | Undetected | |||
| 1 | 20 | AR | 0.85 | 4.25 | 1.21 | 6.30 | 50 |
ND: not done (lost contact)
XR :X-linked recessive
AR :autosomal recessive
Hormonal profile and GnRH stimulation test in adult female patients with KS.
| FAMILY | Age | Inheritance | Base line LH (mIU/ml) N= | Peak LH (mIU/ml) after GnRH testing | Peak LH (mIU/ml) after priming | Base line FSH (mIU/ml) N= | Peak FSH (mIU/ml) After GnRH testing | Peak FSH (mIU/ml) after priming | Estradiol Pg/ml | |
| X | 1 | 23 | AR | 0.6 | 7.25 | 2.6 | 19.33 | 5 | ||
| 2 | 21 | AR | 0.5 | 3.5 | 1.95 | 6.60 | 7 | |||
| 3 | 18 | AR | 0.6 | 5.2 | 1.2 | 9.5 | 10 | |||
| IX | 1 | 18 | sporadic | 0.8 | 5.10 | 2.1 | 5.6 | 15 | ||
| XI | 1 | 30 | sporadic | 0.7 | 4.2 | 1.5 | 6.2 | 10 | ||
| XII | 1 | 18 | sporadic | Undetected | 2.10 | 2.1 | 5.8 | Undetected |
AR :autosomal recessive